Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Primary Care ERectile Function Outcome Registry for Men

Study ID: NCT07356609
Start Date: 2026-02-06
End Date: 2027-05-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

255

Intervention / Treatment
Sponsor

Nabiqasim Industries (Pvt) Ltd

Source: clinicaltrials.gov

Share:
Add to list

Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's Disease

Study ID: NCT07280299
Start Date: 2026-05-30
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

111

Intervention / Treatment

Low Dose GT-02287

High Dose GT-02287

Placebo

Sponsor

Gain Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

Study ID: NCT03867487
Start Date: 2027-05-01
End Date: 2028-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Empagliflozin 10 MG

Placebo Oral Tablet

Sponsor

Justin Ryder

Source: clinicaltrials.gov

Share:
Add to list

A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies

Study ID: NCT06628687
Start Date: 2026-10-26
End Date: 2035-04-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Omaveloxolone

Sponsor

Biogen

Source: clinicaltrials.gov

Share:
Add to list

Tirzepatide for the Treatment of Cannabis Use Disorder

Study ID: NCT07265752
Start Date: 2026-07-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

6

Intervention / Treatment

Tirzepatide

Placebo

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

N2O for Acute Suicidality and Depression in the ED

Study ID: NCT05710887
Start Date: 2026-10-01
End Date: 2028-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

Nitrous oxide gas for inhalation

Placebo

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

5-Year Follow-up of Children and Mother After Expectant Management Versus Induction of Labor in Low-risk Nulliparous Women at 39 Weeks of Gestation

Study ID: NCT07330336
Start Date: 2026-04
End Date: 2032-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

4200

Intervention / Treatment

Questionnaires

Sponsor

University Hospital, Bordeaux

Source: clinicaltrials.gov

Share:
Add to list

Enhancing the Emergency Department Experience for Older Adults: Study Protocol for the Implementation of a Comfort Menu and Cart

Study ID: NCT06681376
Start Date: 2026-04
End Date: 2027-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

264

Intervention / Treatment

Comfort menu and cart

Sponsor

Syrian-Lebanese Hospital

Source: clinicaltrials.gov

Share:
Add to list

The Efficacy of the iWork.COMP Among Health Care Professionals

Study ID: NCT07018089
Start Date: 2026-06-01
End Date: 2028-05-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

iWork.Comp

Sponsor

University of Coimbra

Source: clinicaltrials.gov

Share:
Add to list

To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer

Study ID: NCT07370818
Start Date: 2026-02-27
End Date: 2031-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

81

Intervention / Treatment

JPI-547

bevacizumab

Sponsor

Onconic Therapeutics Inc.

Source: clinicaltrials.gov

Share:
Add to list